Lung Disease Complicates RA Care - Report - MDSpire

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

  • By

  • Andrea Surnit

  • May 8, 2026

  • 4 min

Share

Clinical Report: Lung Disease Complicates RA Care

Overview

Expand to specify the study's design and its implications for treatment strategies.

Background

Rheumatoid arthritis is a systemic autoimmune disease that can lead to significant morbidity, particularly when complicated by extra-articular manifestations such as chronic lung disease. The management of RA in patients with CLD poses unique challenges, as treatment strategies may be limited by the presence of respiratory comorbidities. Understanding the impact of lung disease on RA treatment outcomes is crucial for optimizing patient care.

Data Highlights

OutcomePatients with CLDPatients without CLD
Remission (SDAI)29.8%44.0%
Functional Status (HAQ-DI ≤ 0.5)36.2%45.3%
Nonadherence to T2T Strategy34.0%18.7%
Serious Adverse EventsHigher risk (adjusted HR 2.53)N/A

Key Findings

  • 29.8% of patients with CLD achieved remission compared to 44.0% without CLD.
  • 36.2% of patients with CLD reached a functional status defined as HAQ-DI ≤ 0.5.
  • 34.0% of patients with CLD were nonadherent to the treat-to-target strategy due to comorbidities or adverse events.
  • Patients with CLD experienced a significantly higher risk of serious adverse events (adjusted HR 2.53).
  • Only 23 out of 47 patients with CLD completed the full 5-year observation period.
  • Worsening ILD was observed in 10 out of 31 patients with baseline ILD during follow-up.

Clinical Implications

Healthcare providers should be aware of the increased complexity in managing RA patients with chronic lung disease, as they may experience worse treatment outcomes and higher rates of serious adverse events. A tailored approach that considers the patient's lung condition and comorbidities is essential for optimizing treatment strategies.

Conclusion

The findings underscore the need for careful monitoring and management of rheumatoid arthritis in patients with chronic lung disease, as their treatment outcomes may be significantly impacted by their respiratory status.

Related Resources & Content

  1. Nomura M, et al., Arthritis Research & Therapy, 2023 -- Lung Disease Complicates RA Care
  2. Clinical Rheumatology — Tracheobronchomalacia Associated with Amyloidosis in a Patient Suffering from Rheumatoid Arthritis
  3. Clinical Rheumatology — Reduced paraoxonase-1 activity correlates with increased oxylipins and the occurrence of small airways disease in individuals with rheumatoid arthritis
  4. Clinical Rheumatology — Short-term Outcomes and Progression Predictors of Interstitial Lung Disease in Patients with Rheumatoid Arthritis Treated with Abatacept
  5. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial
  6. conexiant — RA-ILD: Tracking Function and CT
  7. EULAR Guidelines for RA Management
  8. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial | Clinical Rheumatology | Springer Nature Link
  9. https://rheumatology.org/api/asset/bltaedebda97a351d47

Original Source(s)

Lung Disease Complicates RA Care

  • by Andrea Surnit

  • May 8, 2026

Related Content

SSc May Be Linked to Subtle Cognitive Changes

Cross-sectional study finds domain-specific differences and higher anxiety without global impairment.

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.

A machine learning-based classification model for interstitial lung disease in rheumatoid arthritis